Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in HCV Infected Patients Previously Treated with Placebo: Results of the Deferred Treatment Study (GS-US-342-1446 Study)

Gespeichert in:

Autor*in:	Asselah, T. [verfasserIn] Shafran, S. Bourgeois, S. Lai, C.-L. Cramp, M. Mathurin, P. Willems, B. Nguyen, M.H. Davis, M.N. Huang, K.C. Svarovskaia, E. Osinusi, A. Mcnally, J. Brainard, D. McHutchison, J. Shaikh, O.S. Tran, T.T.

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2016

Umfang:	2

Übergeordnetes Werk:	Enthalten in: Identification of the antigenic region of - Abdelbaky, Hanan H. ELSEVIER, 2018, official journal of the European Association for the Study of the Liver, Amsterdam [u.a.]
Übergeordnetes Werk:	volume:64 ; year:2016 ; number:2 ; pages:827-828 ; extent:2

Links:	Volltext

DOI / URN:	10.1016/S0168-8278(16)01619-6

Katalog-ID:	ELV01381088X

Internformat


LEADER	01000caa a22002652 4500
001	ELV01381088X
003	DE-627
005	20230623111058.0
007	cr uuu---uuuuu
008	180602s2016 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1016/S0168-8278(16)01619-6 \|2 doi
028	5	2	\|a GBVA2016006000007.pica
035			\|a (DE-627)ELV01381088X
035			\|a (ELSEVIER)S0168-8278(16)01619-6
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0		\|a 610
082	0	4	\|a 610 \|q DE-600
082	0	4	\|a 610 \|q VZ
084			\|a 44.44 \|2 bkl
100	1		\|a Asselah, T. \|e verfasserin \|4 aut
245	1	0	\|a Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in HCV Infected Patients Previously Treated with Placebo: Results of the Deferred Treatment Study (GS-US-342-1446 Study)
264		1	\|c 2016
300			\|a 2
336			\|a nicht spezifiziert \|b zzz \|2 rdacontent
337			\|a nicht spezifiziert \|b z \|2 rdamedia
338			\|a nicht spezifiziert \|b zu \|2 rdacarrier
700	1		\|a Shafran, S. \|4 oth
700	1		\|a Bourgeois, S. \|4 oth
700	1		\|a Lai, C.-L. \|4 oth
700	1		\|a Cramp, M. \|4 oth
700	1		\|a Mathurin, P. \|4 oth
700	1		\|a Willems, B. \|4 oth
700	1		\|a Nguyen, M.H. \|4 oth
700	1		\|a Davis, M.N. \|4 oth
700	1		\|a Huang, K.C. \|4 oth
700	1		\|a Svarovskaia, E. \|4 oth
700	1		\|a Osinusi, A. \|4 oth
700	1		\|a Mcnally, J. \|4 oth
700	1		\|a Brainard, D. \|4 oth
700	1		\|a McHutchison, J. \|4 oth
700	1		\|a Shaikh, O.S. \|4 oth
700	1		\|a Tran, T.T. \|4 oth
773	0	8	\|i Enthalten in \|n Elsevier Science \|a Abdelbaky, Hanan H. ELSEVIER \|t Identification of the antigenic region of \|d 2018 \|d official journal of the European Association for the Study of the Liver \|g Amsterdam [u.a.] \|w (DE-627)ELV000433829
773	1	8	\|g volume:64 \|g year:2016 \|g number:2 \|g pages:827-828 \|g extent:2
856	4	0	\|u https://doi.org/10.1016/S0168-8278(16)01619-6 \|3 Volltext
912			\|a GBV_USEFLAG_U
912			\|a GBV_ELV
912			\|a SYSFLAG_U
912			\|a SSG-OLC-PHA
936	b	k	\|a 44.44 \|j Parasitologie \|x Medizin \|q VZ
951			\|a AR
952			\|d 64 \|j 2016 \|e 2 \|h 827-828 \|g 2 \|y 64.2016, 2, S827-, (2 S.)
953			\|2 045F \|a 610

Indexfelder

author_variant	t a ta
matchkey_str	asselahtshafransbourgeoisslaiclcrampmmat:2016----:oobvreptsifxdoeobntofr2ekihvnetdainsrvosyraewtpaeoeutot
hierarchy_sort_str	2016
bklnumber	44.44
publishDate	2016
allfields	10.1016/S0168-8278(16)01619-6 doi GBVA2016006000007.pica (DE-627)ELV01381088X (ELSEVIER)S0168-8278(16)01619-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.44 bkl Asselah, T. verfasserin aut Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in HCV Infected Patients Previously Treated with Placebo: Results of the Deferred Treatment Study (GS-US-342-1446 Study) 2016 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Shafran, S. oth Bourgeois, S. oth Lai, C.-L. oth Cramp, M. oth Mathurin, P. oth Willems, B. oth Nguyen, M.H. oth Davis, M.N. oth Huang, K.C. oth Svarovskaia, E. oth Osinusi, A. oth Mcnally, J. oth Brainard, D. oth McHutchison, J. oth Shaikh, O.S. oth Tran, T.T. oth Enthalten in Elsevier Science Abdelbaky, Hanan H. ELSEVIER Identification of the antigenic region of 2018 official journal of the European Association for the Study of the Liver Amsterdam [u.a.] (DE-627)ELV000433829 volume:64 year:2016 number:2 pages:827-828 extent:2 https://doi.org/10.1016/S0168-8278(16)01619-6 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.44 Parasitologie Medizin VZ AR 64 2016 2 827-828 2 64.2016, 2, S827-, (2 S.) 045F 610
spelling	10.1016/S0168-8278(16)01619-6 doi GBVA2016006000007.pica (DE-627)ELV01381088X (ELSEVIER)S0168-8278(16)01619-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.44 bkl Asselah, T. verfasserin aut Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in HCV Infected Patients Previously Treated with Placebo: Results of the Deferred Treatment Study (GS-US-342-1446 Study) 2016 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Shafran, S. oth Bourgeois, S. oth Lai, C.-L. oth Cramp, M. oth Mathurin, P. oth Willems, B. oth Nguyen, M.H. oth Davis, M.N. oth Huang, K.C. oth Svarovskaia, E. oth Osinusi, A. oth Mcnally, J. oth Brainard, D. oth McHutchison, J. oth Shaikh, O.S. oth Tran, T.T. oth Enthalten in Elsevier Science Abdelbaky, Hanan H. ELSEVIER Identification of the antigenic region of 2018 official journal of the European Association for the Study of the Liver Amsterdam [u.a.] (DE-627)ELV000433829 volume:64 year:2016 number:2 pages:827-828 extent:2 https://doi.org/10.1016/S0168-8278(16)01619-6 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.44 Parasitologie Medizin VZ AR 64 2016 2 827-828 2 64.2016, 2, S827-, (2 S.) 045F 610
allfields_unstemmed	10.1016/S0168-8278(16)01619-6 doi GBVA2016006000007.pica (DE-627)ELV01381088X (ELSEVIER)S0168-8278(16)01619-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.44 bkl Asselah, T. verfasserin aut Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in HCV Infected Patients Previously Treated with Placebo: Results of the Deferred Treatment Study (GS-US-342-1446 Study) 2016 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Shafran, S. oth Bourgeois, S. oth Lai, C.-L. oth Cramp, M. oth Mathurin, P. oth Willems, B. oth Nguyen, M.H. oth Davis, M.N. oth Huang, K.C. oth Svarovskaia, E. oth Osinusi, A. oth Mcnally, J. oth Brainard, D. oth McHutchison, J. oth Shaikh, O.S. oth Tran, T.T. oth Enthalten in Elsevier Science Abdelbaky, Hanan H. ELSEVIER Identification of the antigenic region of 2018 official journal of the European Association for the Study of the Liver Amsterdam [u.a.] (DE-627)ELV000433829 volume:64 year:2016 number:2 pages:827-828 extent:2 https://doi.org/10.1016/S0168-8278(16)01619-6 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.44 Parasitologie Medizin VZ AR 64 2016 2 827-828 2 64.2016, 2, S827-, (2 S.) 045F 610
allfieldsGer	10.1016/S0168-8278(16)01619-6 doi GBVA2016006000007.pica (DE-627)ELV01381088X (ELSEVIER)S0168-8278(16)01619-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.44 bkl Asselah, T. verfasserin aut Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in HCV Infected Patients Previously Treated with Placebo: Results of the Deferred Treatment Study (GS-US-342-1446 Study) 2016 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Shafran, S. oth Bourgeois, S. oth Lai, C.-L. oth Cramp, M. oth Mathurin, P. oth Willems, B. oth Nguyen, M.H. oth Davis, M.N. oth Huang, K.C. oth Svarovskaia, E. oth Osinusi, A. oth Mcnally, J. oth Brainard, D. oth McHutchison, J. oth Shaikh, O.S. oth Tran, T.T. oth Enthalten in Elsevier Science Abdelbaky, Hanan H. ELSEVIER Identification of the antigenic region of 2018 official journal of the European Association for the Study of the Liver Amsterdam [u.a.] (DE-627)ELV000433829 volume:64 year:2016 number:2 pages:827-828 extent:2 https://doi.org/10.1016/S0168-8278(16)01619-6 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.44 Parasitologie Medizin VZ AR 64 2016 2 827-828 2 64.2016, 2, S827-, (2 S.) 045F 610
allfieldsSound	10.1016/S0168-8278(16)01619-6 doi GBVA2016006000007.pica (DE-627)ELV01381088X (ELSEVIER)S0168-8278(16)01619-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.44 bkl Asselah, T. verfasserin aut Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in HCV Infected Patients Previously Treated with Placebo: Results of the Deferred Treatment Study (GS-US-342-1446 Study) 2016 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Shafran, S. oth Bourgeois, S. oth Lai, C.-L. oth Cramp, M. oth Mathurin, P. oth Willems, B. oth Nguyen, M.H. oth Davis, M.N. oth Huang, K.C. oth Svarovskaia, E. oth Osinusi, A. oth Mcnally, J. oth Brainard, D. oth McHutchison, J. oth Shaikh, O.S. oth Tran, T.T. oth Enthalten in Elsevier Science Abdelbaky, Hanan H. ELSEVIER Identification of the antigenic region of 2018 official journal of the European Association for the Study of the Liver Amsterdam [u.a.] (DE-627)ELV000433829 volume:64 year:2016 number:2 pages:827-828 extent:2 https://doi.org/10.1016/S0168-8278(16)01619-6 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.44 Parasitologie Medizin VZ AR 64 2016 2 827-828 2 64.2016, 2, S827-, (2 S.) 045F 610
language	English
source	Enthalten in Identification of the antigenic region of Amsterdam [u.a.] volume:64 year:2016 number:2 pages:827-828 extent:2
sourceStr	Enthalten in Identification of the antigenic region of Amsterdam [u.a.] volume:64 year:2016 number:2 pages:827-828 extent:2
format_phy_str_mv	Article
bklname	Parasitologie
institution	findex.gbv.de
dewey-raw	610
isfreeaccess_bool	false
container_title	Identification of the antigenic region of
authorswithroles_txt_mv	Asselah, T. @@aut@@ Shafran, S. @@oth@@ Bourgeois, S. @@oth@@ Lai, C.-L. @@oth@@ Cramp, M. @@oth@@ Mathurin, P. @@oth@@ Willems, B. @@oth@@ Nguyen, M.H. @@oth@@ Davis, M.N. @@oth@@ Huang, K.C. @@oth@@ Svarovskaia, E. @@oth@@ Osinusi, A. @@oth@@ Mcnally, J. @@oth@@ Brainard, D. @@oth@@ McHutchison, J. @@oth@@ Shaikh, O.S. @@oth@@ Tran, T.T. @@oth@@
publishDateDaySort_date	2016-01-01T00:00:00Z
hierarchy_top_id	ELV000433829
dewey-sort	3610
id	ELV01381088X
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV01381088X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623111058.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2016 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0168-8278(16)01619-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016006000007.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV01381088X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0168-8278(16)01619-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.44</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Asselah, T.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in HCV Infected Patients Previously Treated with Placebo: Results of the Deferred Treatment Study (GS-US-342-1446 Study)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">2</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shafran, S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bourgeois, S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lai, C.-L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cramp, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mathurin, P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Willems, B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nguyen, M.H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Davis, M.N.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huang, K.C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Svarovskaia, E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Osinusi, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mcnally, J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brainard, D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McHutchison, J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shaikh, O.S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tran, T.T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Abdelbaky, Hanan H. ELSEVIER</subfield><subfield code="t">Identification of the antigenic region of</subfield><subfield code="d">2018</subfield><subfield code="d">official journal of the European Association for the Study of the Liver</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000433829</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:64</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:827-828</subfield><subfield code="g">extent:2</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0168-8278(16)01619-6</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.44</subfield><subfield code="j">Parasitologie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">64</subfield><subfield code="j">2016</subfield><subfield code="e">2</subfield><subfield code="h">827-828</subfield><subfield code="g">2</subfield><subfield code="y">64.2016, 2, S827-, (2 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
author	Asselah, T.
spellingShingle	Asselah, T. ddc 610 bkl 44.44 Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in HCV Infected Patients Previously Treated with Placebo: Results of the Deferred Treatment Study (GS-US-342-1446 Study)
authorStr	Asselah, T.
ppnlink_with_tag_str_mv	@@773@@(DE-627)ELV000433829
format	electronic Article
dewey-ones	610 - Medicine & health
delete_txt_mv	keep
author_role	aut
collection	elsevier
remote_str	true
illustrated	Not Illustrated
topic_title	610 610 DE-600 610 VZ 44.44 bkl Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in HCV Infected Patients Previously Treated with Placebo: Results of the Deferred Treatment Study (GS-US-342-1446 Study)
topic	ddc 610 bkl 44.44
topic_unstemmed	ddc 610 bkl 44.44
topic_browse	ddc 610 bkl 44.44
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	zu
author2_variant	s s ss s b sb c l l cll m c mc p m pm b w bw m n mn m d md k h kh e s es a o ao j m jm d b db j m jm o s os t t tt
hierarchy_parent_title	Identification of the antigenic region of
hierarchy_parent_id	ELV000433829
dewey-tens	610 - Medicine & health
hierarchy_top_title	Identification of the antigenic region of
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)ELV000433829
title	Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in HCV Infected Patients Previously Treated with Placebo: Results of the Deferred Treatment Study (GS-US-342-1446 Study)
ctrlnum	(DE-627)ELV01381088X (ELSEVIER)S0168-8278(16)01619-6
title_full	Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in HCV Infected Patients Previously Treated with Placebo: Results of the Deferred Treatment Study (GS-US-342-1446 Study)
author_sort	Asselah, T.
journal	Identification of the antigenic region of
journalStr	Identification of the antigenic region of
lang_code	eng
isOA_bool	false
dewey-hundreds	600 - Technology
recordtype	marc
publishDateSort	2016
contenttype_str_mv	zzz
container_start_page	827
author_browse	Asselah, T.
container_volume	64
physical	2
class	610 610 DE-600 610 VZ 44.44 bkl
format_se	Elektronische Aufsätze
author-letter	Asselah, T.
doi_str_mv	10.1016/S0168-8278(16)01619-6
dewey-full	610
title_sort	sofosbuvir/velpatasvir fixed dose combination for 12 weeks in hcv infected patients previously treated with placebo: results of the deferred treatment study (gs-us-342-1446 study)
title_auth	Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in HCV Infected Patients Previously Treated with Placebo: Results of the Deferred Treatment Study (GS-US-342-1446 Study)
collection_details	GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA
container_issue	2
title_short	Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in HCV Infected Patients Previously Treated with Placebo: Results of the Deferred Treatment Study (GS-US-342-1446 Study)
url	https://doi.org/10.1016/S0168-8278(16)01619-6
remote_bool	true
author2	Shafran, S. Bourgeois, S. Lai, C.-L. Cramp, M. Mathurin, P. Willems, B. Nguyen, M.H. Davis, M.N. Huang, K.C. Svarovskaia, E. Osinusi, A. Mcnally, J. Brainard, D. McHutchison, J. Shaikh, O.S. Tran, T.T.
author2Str	Shafran, S. Bourgeois, S. Lai, C.-L. Cramp, M. Mathurin, P. Willems, B. Nguyen, M.H. Davis, M.N. Huang, K.C. Svarovskaia, E. Osinusi, A. Mcnally, J. Brainard, D. McHutchison, J. Shaikh, O.S. Tran, T.T.
ppnlink	ELV000433829
mediatype_str_mv	z
isOA_txt	false
hochschulschrift_bool	false
author2_role	oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth
doi_str	10.1016/S0168-8278(16)01619-6
up_date	2024-07-06T19:51:36.328Z
_version_	1803860570359726080
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV01381088X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623111058.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2016 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0168-8278(16)01619-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016006000007.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV01381088X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0168-8278(16)01619-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.44</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Asselah, T.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in HCV Infected Patients Previously Treated with Placebo: Results of the Deferred Treatment Study (GS-US-342-1446 Study)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">2</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shafran, S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bourgeois, S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lai, C.-L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cramp, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mathurin, P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Willems, B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nguyen, M.H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Davis, M.N.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huang, K.C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Svarovskaia, E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Osinusi, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mcnally, J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brainard, D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McHutchison, J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shaikh, O.S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tran, T.T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Abdelbaky, Hanan H. ELSEVIER</subfield><subfield code="t">Identification of the antigenic region of</subfield><subfield code="d">2018</subfield><subfield code="d">official journal of the European Association for the Study of the Liver</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000433829</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:64</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:827-828</subfield><subfield code="g">extent:2</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0168-8278(16)01619-6</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.44</subfield><subfield code="j">Parasitologie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">64</subfield><subfield code="j">2016</subfield><subfield code="e">2</subfield><subfield code="h">827-828</subfield><subfield code="g">2</subfield><subfield code="y">64.2016, 2, S827-, (2 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
score	7.399008

Nicht das Richtige dabei?

Schreiben Sie uns!

Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in HCV Infected Patients Previously Treated with Placebo: Results of the Deferred Treatment Study (GS-US-342-1446 Study)

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?